SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-22-003056
Filing Date
2022-08-11
Accepted
2022-08-11 06:32:38
Documents
37
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk2228270.htm   iXBRL 10-Q 954356
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 12190
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 12355
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 4624
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 4537
  Complete submission text file 0001178913-22-003056.txt   3683513

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE entx-20220630.xsd EX-101.SCH 46366
7 XBRL CALCULATION FILE entx-20220630_cal.xml EX-101.CAL 30961
8 XBRL DEFINITION FILE entx-20220630_def.xml EX-101.DEF 73235
9 XBRL LABEL FILE entx-20220630_lab.xml EX-101.LAB 753447
10 XBRL PRESENTATION FILE entx-20220630_pre.xml EX-101.PRE 165843
31 EXTRACTED XBRL INSTANCE DOCUMENT zk2228270_htm.xml XML 300032
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38556 | Film No.: 221153560
SIC: 2836 Biological Products, (No Diagnostic Substances)